In Vitro Evaluation of Probiotic Activities and Anti-Obesity Effects of Enterococcus faecalis EF-1 in Mice Fed a High-Fat Diet
2024

Probiotic Effects of Enterococcus faecalis EF-1 on Obesity in Mice

Sample size: 32 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cai Hongying, Wang Qingya, Han Xiling, Zhang Haiou, Wang Na, Huang Yuyin, Yang Peilong, Zhang Rui, Meng Kun

Primary Institution: Key Laboratory of Feed Biotechnology of Ministry of Agriculture and Rural Affairs, Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing, China

Hypothesis

This research sought to assess the anti-obesity potential of Enterococcus faecalis EF-1.

Conclusion

E. faecalis EF-1 inhibits high-fat diet-induced obesity by regulating gut microbiota and enhancing short-chain fatty acid production.

Supporting Evidence

  • E. faecalis EF-1 significantly reduced body weight gain in mice on a high-fat diet.
  • The strain improved gut microbiota balance by decreasing the Firmicutes/Bacteroidetes ratio.
  • EF-1 enhanced the production of short-chain fatty acids in the gut.
  • Treatment with EF-1 led to lower levels of triglycerides and glucose in serum.
  • EF-1 showed antimicrobial activity against several pathogenic strains.

Takeaway

This study found that a probiotic called E. faecalis EF-1 can help mice lose weight and improve their gut health when they eat a high-fat diet.

Methodology

The study involved in vitro assessments of E. faecalis EF-1's probiotic properties and in vivo experiments on mice fed a high-fat diet.

Limitations

The research was limited to a mouse model, restricting the extrapolation of findings to human applications.

Participant Demographics

Male C57BL/6J mice, aged 7 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/foods13244095

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication